EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 21-Oct-2026 14:16 ET (21-Oct-2026 18:16 GMT/UTC)

18-Sep-2026

Proven radiotracer highly effective in detecting rare, aggressive kidney cancer

Society of Nuclear Medicine and Molecular Imaging
Peer-Reviewed Publication

Renal medullary carcinoma (RMC) demonstrates strong uptake of the radiotracer ¹⁸F-FDG, distinguishing it from other types of kidney cancer which often have more variable uptake. ¹⁸F-FDG PET/CT was found to be highly effective even after systemic treatment and detected additional metastases missed by conventional anatomic imaging, providing a more complete picture of how far the cancer had spread. This research was published in the September issue of The Journal of Nuclear Medicine.

Journal: Journal of Nuclear Medicine

18-Sep-2026

Gene that drives blood cancer drug resistance uncovered with new CRISPR activation tool

Olivia Newton-John Cancer Research Institute
Peer-Reviewed Publication

Researchers have uncovered a previously unknown gene causing resistance to a leading blood cancer drug and several genes that accelerate lymphoma growth, using a powerful new CRISPR activation library.

Journal: Science Advances
Funder: Victorian Cancer Agency, Cancer Council Victoria, National Health and Medical Research Council, National Health and Medical Research Council, National Health and Medical Research Council, Victorian Cancer Agency, Craig Perkins Cancer Research Foundation, Harry Secomb Foundation, Estate of Anthony (Toni) Redstone OAM, Australian Lions Childhood Cancer Research Foundation, National Health and Medical Research Council, National Health and Medical Research Council, National Health and Medical Research Council, National Health and Medical Research Council, National Health and Medical Research Council, Cancer Council Victoria

18-Sep-2026

Loss of Y chromosome in men could be early warning sign of cancer

University of Arizona
Peer-Reviewed Publication

New research has found that Y chromosome loss occurs in healthy-seeming tissue before tumors begin to form, making the loss of a hormone an early indicator of cancer danger.

Journal: JCI Insight

18-Sep-2026

Researchers uncover how aggressive breast cancer may spread to the brain

Wake Forest University School of Medicine
Peer-Reviewed Publication

Wake Forest University School of Medicine researchers identified SIRPα as a protein that may help triple-negative breast cancer spread to the brain and evade immune defenses, offering a potential target for future treatments.

Journal: Neuro-Oncology
Funder: American Society for Radiation Oncology, Lewis-Michael Miracle Fund, American Cancer Society

18-Sep-2026

University Hospitals researchers find major increase in the use of MRI before prostate biopsy

University Hospitals Cleveland Medical Center
Peer-Reviewed Publication

In 2026, two thirds of men undergoing a first prostate biopsy underwent an MRI beforehand

Any man facing a biopsy should be asking whether an MRI is appropriate for him, because it changes both whether a biopsy is needed and where the needles go

Researchers saw MRI use fall off in men with very high PSA levels and in men over 80, which may reflect reasonable clinical judgment in some cases, but is worth examining rather than assuming

MRI use increasing is a good thing, but there are still real gaps and issues with MRI quality

Journal: JAMA Oncology

18-Sep-2026

B cells may help predict risk of colitis from immunotherapy

University of Texas M. D. Anderson Cancer Center
Peer-Reviewed Publication

Researchers at The University of Texas MD Anderson Cancer Center have identified a previously unknown role for B cells, which are adaptive immune cells, in triggering and sustaining colitis occurring as a side effect of immune checkpoint inhibitors, a widely used form of cancer immunotherapy.

Journal: Cell Reports

17-Sep-2026

Study shows reprogramming thyroid tumors may improve CAR-T cell therapy

Mayo Clinic
Peer-Reviewed Publication

Mayo Clinic researchers have identified a strategy that could help chimeric antigen receptor-T cell therapy, or CAR-T cell therapy, overcome a major barrier to treating solid tumors: Cancer cells can change in ways that allow them to hide from immune cells designed to attack them.

Journal: Molecular Cancer

17-Sep-2026

New method identifies leukemia drug candidates and target

Rice University
Peer-Reviewed Publication

Rice University’s Natasha Kirienko is interested in finding and exploiting cancer cell vulnerabilities to advance cancer treatments. In a paper recently published in the journal Leukemia, her team used a new screening method to identify drugs that could target the vulnerabilities of AML cells without unduly harming healthy cells.

Journal: Leukemia

17-Sep-2026

Virtual cells built from 4D AI models and "Digital twins” could speed up drug discovery

University of California - San Diego
Peer-Reviewed Publication

UC SanDiego researchers are using AI and "virtual cells" based on 4D movies to predict how cells will respond to drugs, which could speed up drug discovery for cancer, Alzheimer’s and more.

Journal: Cell

17-Sep-2026

Blood test trends may help identify patients at increased risk of cancer

PLOS
Peer-Reviewed Publication

Blood test trends alongside unexplained weight loss can improve triage for cancer testing, according to a study by Brian Nicholson and colleagues from the University of Oxford, UK, published September 17^th in the open access journal PLOS Medicine.

Journal: PLOS Medicine